Johnson and Johnson

U.S. FDA approves biocon biologics' yesintek™, bmab 1200 biosimilar to j&j's Stelara®… PR Newswire (Press Release)12:02
'Why I blame Johnson and Johnson baby talc for cancer that robbed me of my voice' The Mirror12:45
Mallow stem student receives scholarship The Corkman12:20
Johnson & Johnson exec signs on for Algorae AI drug development The Sydney Morning Herald04:51
Beasley Allen escapes sanctions for j&j deposition no show Law36001:04
Beasley Allen rips j&j sanctions bid for atty depo no-show Law36021:32
Johnson & Johnson: Thousands plan legal action over alleged talc and cancer link Bucks Free Press15:43

Latest News

Yesterday
J&J Talc Cases to Remain on Hold Until Mid-March, Judge Rules Bloomberg Law20:58 2-Dec-24
Johnson & Johnson Files SBLAs In Pediatric Indications For Tremfya - Quick Facts RTT News13:37 2-Dec-24
Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA® (guselkumab) Johnson & Johnson (Press Release)13:04 2-Dec-24
MENTOR™ MemoryGel™ Enhance Breast Implant Receives FDA Approval for Largest Size Breast Implants for Reconstruction Johnson & Johnson (Press Release)13:04 2-Dec-24
U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&J's Stelara®… PR Newswire (Press Release)12:02 2-Dec-24
Money for Nothing? In an About Face, This Time the Third Circuit Said “Yes” Drug & Device Law10:04 2-Dec-24
Expansion of Johnson & Johnson on the Leiden Bio Science Park Leiden University09:51 2-Dec-24
In the last 7 days
Unlocking the Innovation Potential in Singapore’s Life Sciences Ecosystem BioSpectrum Asia19:18 1-Dec-24
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later The Motley Fool10:57 1-Dec-24
How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding Seeking Alpha20:00 28-Nov-24
3 Blue-Chip Stocks to Anchor Your Portfolio Entrepreneur Magazine12:37 28-Nov-24
Mallow stem student receives scholarship The Corkman12:20 28-Nov-24
J&J Sues HRSA Over Agency’s Challenge of its Rebate Model JD Supra07:22 28-Nov-24
Johnson & Johnson exec signs on for Algorae AI drug development The Sydney Morning Herald04:51 28-Nov-24
Baby Oral Care Products Market Global Forecasts and Company Analysis 2024-2032, Featuring Church & Dwight,… GlobeNewswire (Press Release)15:49 27-Nov-24
Johnson & Johnson announce recipients of Women in STEM2D Undergraduate Awards Business Plus Online14:07 27-Nov-24
Johnson & Johnson a Top 25 Dividend Giant With 3.21% Yield (JNJ) Nasdaq13:11 27-Nov-24
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape Drug Discovery & Development07:40 27-Nov-24
Beasley Allen Escapes Sanctions For J&J Deposition No Show Law36001:04 27-Nov-24
Derry woman among hundreds who may sue Johnson & Johnson over talc cancer claims Belfast Live17:58 26-Nov-24
Sanofi joins J&J, Eli Lilly in proposing 340B rebate model Healthcare Dive16:01 26-Nov-24
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since… Johnson & Johnson (Press Release)15:13 26-Nov-24
2 Very Healthy Dividend Stocks to Hold for Decades of Income The Motley Fool11:25 26-Nov-24
In the last month
Notable Monday Option Activity: MCD, ALB, JNJ Nasdaq19:58 25-Nov-24
After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists Johnson & Johnson (Press Release)16:10 25-Nov-24
J&J and Protagonist share promising phase 3 results for icotrokinra in plaque psoriasis PMLiVE12:32 25-Nov-24
Johnson & Johnson: Thousands plan legal action over alleged talc and cancer link Bucks Free Press15:43 24-Nov-24
'Why I blame Johnson and Johnson baby talc for cancer that robbed me of my voice' The Mirror12:45 23-Nov-24
Sanofi Offers New Payment Model for Drug Discount Program Bloomberg Law23:40 22-Nov-24
Read This Before Considering Johnson & Johnson (NYSE:JNJ) For Its Upcoming US$1.24 Dividend Simply Wall St22:50 22-Nov-24
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement Benzinga20:40 22-Nov-24
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis Pharmaceutical Technology17:40 22-Nov-24
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings Nasdaq16:53 22-Nov-24
Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma Pharmaceutical Technology16:18 22-Nov-24
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals Forbes14:44 22-Nov-24
Johnson & Johnson Submits Sbla Seeking Approval Of Tremfya In Ulcerative Colitis RTT News13:52 22-Nov-24
Antihistamine Drugs Industry Report 2025-2030: A $381 Million Opportunity - Johnson & Johnson, Sanofi, Pfizer, and… GlobeNewswire (Press Release)13:41 22-Nov-24
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA®… PR Newswire (Press Release)13:01 22-Nov-24
UK claimants propose legal action against Johnson & Johnson over talc cancer claims British Medical Journal11:51 22-Nov-24
KP Law Leads Fight for Justice and Compensation in UK Johnson & Johnson Talc Cancer Cases Lawyer Monthly16:58 21-Nov-24
Irish woman battling cancer among thousands suing Johnson & Johnson over ‘baby powder link’ Sunday World15:23 21-Nov-24
'My wife died from ovarian cancer - talcum powder was to blame' Essex Live12:14 21-Nov-24
Derry woman joins lawsuit over talc cancer claims BBC10:50 21-Nov-24
Women plan to sue over talcum powder cancer claim Stoke-On-Trent Live10:28 21-Nov-24
Enclony partners with Johnson & Johnson on drug sample inspection project Korea Biomedical Review09:03 21-Nov-24
NI woman battling cancer among thousands suing over ‘baby powder link’ Belfast Telegraph07:45 21-Nov-24
Beasley Allen Rips J&J Sanctions Bid For Atty Depo No-Show Law36021:32 20-Nov-24
Johnson & Johnson now risks UK lawsuit over talc cancer claims News2417:26 20-Nov-24
Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll FiercePharma16:39 20-Nov-24
Johnson & Johnson risks UK lawsuit over talc cancer claim YEN16:27 20-Nov-24
Unpacking Johnson & Johnson’s Lawsuit Over 340B Rebate Model JD Supra16:12 20-Nov-24
Derbyshire woman joins planned UK legal action over talc cancer claims Derbyshire Times14:01 20-Nov-24
Devastated dad who lost wife to ovarian cancer could sue amid talc cancer claims Gazette News13:45 20-Nov-24
Thousands of women plan legal action over alleged links between talc and cancer Belfast Telegraph13:26 20-Nov-24
Johnson & Johnson Starkly Portray Reality of Severe Depression with Powerful Film Little Black Book11:12 20-Nov-24
J&J, Merck Cut Jobs in China as Local Competition Takes Toll BNN Bloomberg08:35 20-Nov-24
'We thought talcum powder was safe' BBC06:26 20-Nov-24
J&J Wants Beasley Allen Atty Sanctioned For Depo No-Show Law36021:58 19-Nov-24
Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive Seeking Alpha18:14 19-Nov-24
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the… PR Newswire (Press Release)14:06 19-Nov-24
Biolojic Design Joins Johnson & Johnson Innovation - JLABS GlobeNewswire (Press Release)13:04 19-Nov-24
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis Clinical Trials Arena11:01 19-Nov-24
J&J plots filings after psoriasis drug clears phase 3 test pharmaphorum10:50 19-Nov-24
J&J Posts $1.17B Bond For Del. Merger Milestone Appeal Law36002:49 19-Nov-24
Johnson & Johnson appoints CIO to lead business technology strategy CIO Dive21:55 18-Nov-24
Icotrokinra delivered an industry-leading combination of significant skin clearance with… PR Newswire (Press Release)21:38 18-Nov-24
Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences JD Supra19:40 18-Nov-24
Court closes case against Johnson&Johnson baby powder The Star, Kenya10:54 18-Nov-24
Microstrategy’s $26 Billion Bitcoin Stash Now Exceeds IBM and Nike Holdings Coinpedia09:33 17-Nov-24
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program Investopedia19:00 15-Nov-24
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of… GlobeNewswire (Press Release)15:17 15-Nov-24
Tremfya's Promising Debut Boosts Momentum for IL-23 Class in Ulcerative Colitis Treatment, According to Spherix Global… GlobeNewswire (Press Release)14:39 15-Nov-24
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga12:29 15-Nov-24
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial Clinical Trials Arena11:56 15-Nov-24
Johnson & Johnson MedTech announces partnership for soft tissue solutions Verdict Medical Devices11:54 15-Nov-24
Ex-Worker Says Johnson & Johnson Fired Her For Disabilities Law36021:46 14-Nov-24
Connecticut Jury Awards $15 Million Talc Verdict against Johnson & Johnson Entities JD Supra20:21 14-Nov-24
Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction … PR Newswire (Press Release)15:02 14-Nov-24
Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue… Johnson & Johnson (Press Release)13:24 14-Nov-24
J&J sues federal government for halting 340B rebate plan Healthcare Dive21:42 13-Nov-24
Johnson & Johnson: Tracking Well Above The Industry Seeking Alpha20:58 13-Nov-24
DOJ Objects to J&J Unit Hiring Jones Day as Bankruptcy Counsel Bloomberg Law20:38 13-Nov-24
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot Clinical Trials Arena16:31 13-Nov-24
Johnson & Johnson Challenges Government Drug Pricing Dispute Over Two Drugs Benzinga14:45 13-Nov-24
J&J’s nipocalimab granted FDA breakthrough designation for Sjögren’s disease PMLiVE12:26 13-Nov-24
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class… Business Wire (Press Release)12:04 13-Nov-24
J&J seek approval for first drug to treat high-risk smoldering myeloma Pharmafile10:57 13-Nov-24
J&J Says HHS Is Thwarting Transparency Of Drug Discounts Law36001:50 13-Nov-24
J&J Sues HHS Over Threat to Rebate Model in Drug Discount Plan Bloomberg Law22:40 12-Nov-24
Johnson & Johnson wins FDA exemption for Ottava surgical robot The Robot Report22:02 12-Nov-24
Why Transparency is Critical for Patients Johnson & Johnson (Press Release)20:54 12-Nov-24
Disposable Contact Lenses Focused Insights Market Report 2024-2029 Featuring Prominent Vendors… Business Wire (Press Release)15:38 12-Nov-24
Johnson & Johnson MedTech Receives IDE Approval for OTTAVA™ Robotic Surgical System PR Newswire (Press Release)13:02 12-Nov-24
Stand Up To Cancer partners with Johnson & Johnson to explore new treatment for AL amyloidosis News-Medical.Net12:37 12-Nov-24
J&J submits EU and US applications for subcutaneous Darzalex in smouldering multiple myeloma PMLiVE12:12 12-Nov-24
FDA grants breakthrough status to J&J’s nipocalimab for SjD treatment Pharmaceutical Technology09:37 12-Nov-24
Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy … PR Newswire (Press Release)21:06 11-Nov-24
Johnson & Johnson Seeks FDA Approval of Daratumumab for Smoldering Multiple Myeloma Pharmacy Times20:41 11-Nov-24
DARZALEX FASPRO®/DARZALEX® (daratumumab) come monoterapia sottocutanea per il mieloma multiplo smouldering ad alto… GlobeNewswire (Press Release)14:44 11-Nov-24
Stand Up To Cancer Collaborates With Johnson & Johnson To Explore Targeted Therapies For Rare… PR Newswire (Press Release)14:04 11-Nov-24
Bristol Myers Squibb Showcases the Continued Strength of its Cardiovascular Portfolio with New… Business Wire (Press Release)12:01 11-Nov-24
J&J bids to add smouldering myeloma to Darzalex label pharmaphorum17:30 10-Nov-24
Jodie is 'proud to bring apprentice prize home to Limerick' Limerick Leader10:01 10-Nov-24
Scimeca: Faulty science claims prolonged talc lawsuit Boston Herald05:28 9-Nov-24
J&J Talc Unit Must Revise Ch. 11 Plan, Insurers Say Law36002:00 9-Nov-24
J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer PharmTech.com18:35 8-Nov-24
Notable Two Hundred Day Moving Average Cross - JNJ Nasdaq16:20 8-Nov-24
Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink? Barchart13:43 8-Nov-24
Johnson & Johnson receive MHRA approval for BALVERSA Pharmafile12:30 8-Nov-24
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab)… GlobeNewswire (Press Release)12:08 8-Nov-24
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®… PR Newswire (Press Release)12:04 8-Nov-24
Johnson & Johnson MedTech’s VARIPULSE Platform receives FDA approval for AFib Verdict Medical Devices10:59 8-Nov-24
Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising… PR Newswire (Press Release)22:39 7-Nov-24
FDA Approves Varipulse Pulsed-Field Ablation System for AF TCTMD21:53 7-Nov-24
Johnson & Johnson MedTech Unveils New Joint Reconstruction Solutions at 2024 AAHKS Annual Meeting Johnson & Johnson (Press Release)13:01 7-Nov-24

      
            
      
    view more headlines
   
      
      
      
2 Dec 20:58
   

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

Johnson and Johnson

Latest News

About our Johnson & Johnson news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories